Business and Finance

Recent FDA actions may finally usher in access boost to follow-on biologics in the US

R&D partnership with VaxEquity outlines plan to use saRNA as a go-to therapeutic

Availability of space for new labs is a key selling point

Acquisition expected to help provide customers with a quicker clinical trial recruitment process

Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot

Latest construction plan continues CDMO’s vision for biopharma expansion

Collaboration earns Adaptimmune an initial payday of $150 million

Supply deal with Takeda to begin distribution in early 2022, pending shot approval

Drug maker to supply European Union with 60 million doses by end of Q3

Swiss organization will take patient-centric approach towards developing injectables

Agreement will focus on developing, manufacturing and commercializing biosimilars in the respiratory space

Meeting future expectations in pharmaceutical sustainability a key component of shipping collaboration

Project will center on equipment and technology improvements, says UK R&D and manufacturing accelerator

Healthcare tech company acquires Medical Marketing Economics, a provider of value-based strategy support

Wholesaler's 3PL arm to provide logistics and distribution support to potential emergency use drug for patients with critical Covid with respiratory failure

CAGR growth through 2026 will be 6.4% per year

Deal for CHC Health adds depth, scale and expanded clinical expertise in health outcomes pursuits

Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site

Acquisition addresses the need for meeting healthcare sector’s patient support demand

Deal allows for bicoastal expansion of pharmaceutical services

How the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings

Plan aims to offset costs associated with proposed social and health initiatives

Among focal points, New Jersey location will support clinical research, pharmacovigilance

WuXi STA will take reigns of the operations, as CDMO expands

State and regional economic-development authorities compete fiercely for siting new pharma enterprises, and holding onto the ones they have. But pharma’s stupendous growth in investment is giving all regions a boost

Sector is expected to be driven by a rise in drug development and regulatory approvals for advanced therapies

Acquisition of US partner establishes Sanofi's plan to advance messenger RNA technology for vaccines, therapeutics

Guidance supports cross-industry collaboration for improved interoperability

Private equity companies see the sector as having a valuable ROI, according to study

Pharmacy discount card company and e-commerce specialist team up on new Rx-med procedures channel